You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 4, October 1954 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

OXYPHENONIUM (ANTRENYL), A SUBSTITUTE FOR ATROPINE

A Clinical Study

IRA A. ABRAHAMSON, Jr., M.D.; PAUL HURWITZ, M.D.

AMA Arch Ophthalmol. 1954;52(4):519-523.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE CONSTANT search for new synthetic mydriatic and cycloplegic drugs as substitutes for homatropine and atropine continues to stimulate the investigator. Most recently, cyclopentylate (Cyclogyl)1 and its allied chemicals* have met with some degree of success as short-acting cycloplegic replacements for homatropine.

Other similar-acting agents,5 whose initial effectiveness proved illusory, have, however, attained limited, though valuable, purposes in the ophthalmological armamentarium. Several such drugs are hydroxyamphetamine (Paredrine), phenylephrine (Neo-Synephrine), eucatropine (Euphthalmine), and Dibutoline.6

There is no adequate long-acting synthetic cycloplegic substitute for atropine. Only BL 1397 (β-β-diphenyl-{gamma}-dimethylaminovaleramide) approaches the efficacy of atropine in its autonomic ganglion-blocking action and its cycloplegic-mydriatic effect. However, it has not been made available.

Oxyphenonium (Antrenyl), as a potential substitute for atropine, came to our attention during the clinical study of its systemic administration, because of its side-reactions—dryness of the mouth and pupillary dilation. The prolonged cycloplegic and mydriatic action of this . . . [Full Text PDF of this Article]


Author Affiliations

CINCINNATI; CHICAGO

From the Eye Department of the Cook County Hospital and Chicago Medical School.


Footnotes

The Antrenyl was supplied by Ciba Pharmaceutical Products, Inc., Summit, N. J.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1954 American Medical Association. All Rights Reserved.